cp 93129 has been researched along with Hypertension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banes, AK; Watts, SW | 2 |
2 other study(ies) available for cp 93129 and Hypertension
| Article | Year |
|---|---|
Arterial expression of 5-HT2B and 5-HT1B receptors during development of DOCA-salt hypertension.
Topics: Animals; Arteries; Desoxycorticosterone; Female; Gene Expression; Hypertension; Indoles; Male; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT2B; Serotonin Antagonists; Serotonin Receptor Agonists; Sodium Chloride; Thiophenes; Vasoconstriction | 2003 |
Enhanced contraction to 5-hydroxytryptamine is not due to "unmasking" of 5-hydroxytryptamine(1b) receptors in the mesenteric artery of the deoxycorticosterone acetate-salt rat.
Topics: Animals; Benzamides; Blood Pressure; Desoxycorticosterone; Dose-Response Relationship, Drug; Hypertension; In Vitro Techniques; Ketanserin; Male; Mesenteric Arteries; Phenylephrine; Potassium Chloride; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Vasoconstriction; Vasoconstrictor Agents | 2001 |